Policy Briefings

Arcturus Therapeutics Selects Thermo Fisher for ARCT-032 Phase 3 Development

Prestige Biopharma Signs Strategic MOU with Charles River Laboratories

Syngene International Appoints Siddharth Mittal as Managing Director and CEO

Gannet BioChem Partners with Serina Therapeutics to Advance Parkinson’s Therapy SER-252

Rentschler Biopharma Appoints Torsten Woehr as CEO Effective August 1, 2026

ProBio Supports GlyTR CAR-T Program with GMP AAV6 Manufacturing

Avista Healthcare Partners Completes Acquisition of Sanotact Group

Lonza Expands Strategic Biologics Manufacturing Collaboration with U.S. Biopharma Company

Morepen Laboratories Begins Commercial Supply Under ₹825 Crore ($95.9 million) CDMO Mandate

Icosagen Completes €45 Million Biologics Manufacturing Expansion in Estonia

The US Reshoring Tide Goes Out: Record CDMO Newsflow, but the Investment Moved Back Offshore in H1 2026

WuXi Biologics Receives ANVISA GMP Certification for Three Manufacturing Facilities

AustinPx Partners with Thermo Fisher to Expand KinetiSol Technology for Commercial Manufacturing

Lonza Expands ADC Payload-Linker Manufacturing Capacity at Visp Site

Evotec Expands Just – Evotec Biologics with New J.TRAIN Manufacturing Platform

C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules

WuXi Biologics Completes First GMP Production at MFG17 Drug Substance Facility

VectorBuilder and MaxCyte Partner to Develop Non-Viral Gene Delivery Platform